Javdat Muratkhodjaev

Dr. Javdat Muratkhodjaev


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1992 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
OKOleg V. Krasilnikov
Oleg V. Krasilnikov
JMJavdat Muratkhodjaev
Javdat Muratkhodjaev
AZAlexander O. Zitzer
Alexander O. Zitzer

26 August 1991 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
OKOleg V. Krasilnikov
Oleg V. Krasilnikov
JMJavdat Muratkhodjaev
Javdat Muratkhodjaev
SVSergei E. Voronov
Sergei E. Voronov
YYYuri V. Yezepchuk
Yuri V. Yezepchuk

30 November 1993 in Zentralblatt für Bakteriologie
Verified
Journal Article
Closed access
AZA.O. Zitzer
A.O. Zitzer
NNN.O. Nakisbekov
N.O. Nakisbekov
ALA.V. Li
A.V. Li
VSV.L. Semiotrochev
V.L. Semiotrochev
YKYu.L. Kiseliov
Yu.L. Kiseliov
YEYu.V. Ezepchuk
Yu.V. Ezepchuk

31 October 2022 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
JMJavdat Muratkhodjaev
Javdat Muratkhodjaev
TAT. U. Aripova
T. U. Aripova
ДМД. Н. Муратходжаев
Д. Н. Муратходжаев
Comparative analysis of antiviral protective mechanisms in protozoa and RNA interference of multicellular organisms has revealed their similarity, also providing a clue to understanding the adaptive immunity. In this article, we present the latest evidence on the importance of RNA-guided gene regulation in human antiviral defense. The role of neutralizing antibodies and interferon system in viral invasion is considered. The new concept has been introduced, i.e., antiviral protection of any living organism is based on the intracellular RNA-guided mechanisms. Simple and effective defense against viruses is that spacer segment of the viral DNA is inserted into the cellular chromosomes. Upon re-infection, the RNA transcript of the spacer directs nuclease enzymes against the foreign genome. This is a really adaptive immune defense that any cell potentially possesses. In humans, the interferon system provides an additional tool for early suppression of viral infections which shifts the cells to the alert regimen, thus preventing further spread of infection. The main task of the human central immune system is to maintain integrity and combat foreign organisms. Accordingly, a suitable index of acquired antiviral immunity should be a presence of specific spacer markers in DNA samples from reconvalescent persons, rather than detection of neutralizing antibodies, B and T memory cells.This article is addressed primarily to general medical community, and its practical conclusions are as follows:1. Presence or absence of specific antibodies to SARS-CoV-2 is not a prognostic sign of the disease. Detection of specific antibodies in blood simply reflects the fact that the person has contacted with the viral agent. Absence of antibodies does not mean a lack of such contact, and the persons with high titers of specific antibodies are not protected from re-infection with SARS-CoV-2.2. PCR testing: The PCR results may remain “false positive” in those subjects who have had COVID-19, if the genetic material is taken from the site of initial virus contraction (mainly, nasopharynx). In our opinion, negative PCR tests for COVID-19 in blood plasma and urine will be a more correct index for the absence of the disease, even with positive PCR tests from the nasopharyngeal samples.3. It is necessary to draw attention of general practitioners to potential usage of retinol in prevention and treatment of COVID-19, given the importance of RLR receptors in recognition of viral RNAs and positive experience of vitamin A administration in measles, another dangerous viral disease.

22 December 2025 in International Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
HHHong Huang
Hong Huang
JMJavdat Muratkhodjaev
Javdat Muratkhodjaev
YGYanhong Gong
Yanhong Gong
JLJing Liu
Jing Liu
JLJu Liu
Ju Liu
Severe heart failure (HF) is accompanied by cardiac cachexia (CC), defined as significant weight loss, muscle atrophy, and metabolic abnormalities. Muscle wasting in patients with CC is closely associated with hormonal changes. Previous studies on the pathogenesis of CC have focused on the imbalance between catabolic and anabolic processes. Thus, this review focused on the role of endothelial dysfunction in CC. We summarized how inflammatory cytokines and neurohormonal factors cause vascular dysfunction, leading to reduced nutrient delivery and perfusion. Furthermore, we discuss both conventional and emerging therapeutic strategies that may ameliorate CC by targeting the vasculature. These include ghrelin, the vascular benefits of foundational HF drugs (angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor-neprilysin inhibitors (ARNIs), and beta-blockers), and the promise of novel agents, such as BTB and CNC homology 1 (BACH1) inhibitors and fibroblast growth factor 21 (FGF21) agonists. We also summarize the existing animal models of CC and discuss advanced imaging and omics technologies for future research. This review provides a novel perspective on CC pathogenesis and highlights promising avenues for therapeutic intervention.

25 September 2025 in Aging Pathobiology and Therapeutics
Verified
Journal Article
Open access
PDF file
SMSaodat A. Muratkhodjaeva
Saodat A. Muratkhodjaeva
JMJavdat Muratkhodjaev
Javdat Muratkhodjaev
TATamara U. Aripova
Tamara U. Aripova
Experimental confirmation of osteoarthritis repair in vivo using epigenetic reprogramming with small molecules